Need Help? Call 1­-866-­796-­7386
« back to stock screener

  ABCL stock: AbCellera Biologics Inc

Current Rating
Sell

Previous Rating

Strong Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$7.55
Market Cap
2.35B
Sector
Health Care
Div. Growth
-
P/E
16.9
P/B
1.95
P/S
4.94
Dividend %
-
P/CF
-
P/FCF
11.2
Op. Cash Flow
277.4K
FCF
0.7
Op. Margin
44.60%
Net Margin
32.70%
ROE
12.90%
ROI
11.00%
ROA
10.10%
EPS Growth
-0.50%
Current Ratio
8.7
Debt/Equity
-
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Amneal Pharmaceuticals Inc (AMRX) $1.27 - - 604.1M Strong Buy
Alaunos Therapeutics Inc (TCRT) $0.60 - - 137M Strong Buy
Akumin Inc (AKU) $0.74 - - 108.7M Strong Buy
Cidara Therapeutics Inc (CDTX) $1.19 - - 129.6M Strong Buy
Akebia Therapeutics Inc (AKBA) $0.60 - - 171M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More